FINANCIALS

PTGX Protagonist Therapeutics Inc 1377121

Income Statement
Revenue	ptgx-20241231x10k	434,433,000
Net Income	ptgx-20241231x10k	275,188,000
Profit Margin		63.34%

Balance Sheet
Current Assets	591,641,000
Assets	744,725,000
Current Liabilities	47,398,000
Liabilities	69,430,000
Equity	675,295,000
Shares Out	58,905,000

Cash Flow Statement
Operating Cash Flow	184,152,000
Investing Cash Flow	-299,483,000

Market Analysis
Market Cap	2,680,158,845
Price	53.22
BVPS	11.46
PB	4.69
EPS	2.64
PE	17.25
PS	1.54
FCF	-115,331,000

Dividends

Earnings

Find a discrepancy? The most accurate way to find company fundamental data is to view PTGX documents filed with the SEC.

PTGX Filings Clear

View A List of Tickers